Importation Of Us-labelled Pancuronium Bromide Injection Due To Shortage Of Neuromuscular Blocker Products
Recall Summary Health Canada has allowed the importation of US-labelled pancuronium bromide injection into Canada to address a shortage of neuromuscular blocking medications used during surgery and anesthesia. The product is being imported from the United States with US labelling rather than Canadian labelling due to supply constraints. This temporary measure affects hospitals and medical facilities across Canada that use this medication.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-04-29
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/f495b368-7642-445d-b785-82a06460553d